Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing respiratory muscle effort during noninvasive respiratory support in acute hypoxemic respiratory failure: A State-of-the Art Review from physiology to bedside.

Intensive & critical care nursing·2026
Same author

Sedation in Acute Ischemic Stroke: Pathophysiological Basis and Evidence for Commonly Used Agents.

Translational stroke research·2026
Same author

Correction: Utilization of Neuromuscular Blocking Agents in Acute Brain Injury and Associations with Outcomes: A Post Hoc Analysis of the ENIO Study.

Neurocritical care·2026
Same author

Cytokine storm in acute respiratory distress syndrome.

Journal of intensive medicine·2026
Same author

Mechanical Power of Ventilation: The Good, the Bad, and the Ugly.

Critical care medicine·2026
Same author

Two-Lung Ventilation Attenuates Systemic Inflammatory and Oxidative Stress Responses During Thoracic Surgery: A Randomized Clinical Trial.

Journal of cardiothoracic and vascular anesthesia·2026
Same journal

Translational validity of rodent diet-induced obesity models for cognitive impairment in human metabolic disease.

Anais da Academia Brasileira de Ciencias·2026
Same journal

Lateral dominance and (as)symmetry in 50 m all-out front crawl.

Anais da Academia Brasileira de Ciencias·2026
Same journal

Vitamin A and its relationship with insulin secretion and diabetes mellitus: a review.

Anais da Academia Brasileira de Ciencias·2026
Same journal

Abundance, biomass and variability of the demersal mesozooplankton during contrasting seasons on a shallow reef ecosystem.

Anais da Academia Brasileira de Ciencias·2026
Same journal

Judicial decision sets Restinga coastal ecosystem at high risk in Brazil.

Anais da Academia Brasileira de Ciencias·2026
Same journal

Conservation, diversity, and evaluation of Cassava landraces for northern Mato Grosso.

Anais da Academia Brasileira de Ciencias·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Intranasal Delivery of mRNA Polyplexes via Rayleigh Breakup Aerosols: An In Vitro Method for Nasal Deposition and Functional Testing
05:50

Intranasal Delivery of mRNA Polyplexes via Rayleigh Breakup Aerosols: An In Vitro Method for Nasal Deposition and Functional Testing

Published on: January 20, 2026

Nanoparticle-based therapy for respiratory diseases.

Adriana L Da Silva1, Raquel S Santos, Débora G Xisto

  • 1Laboratório de Investigação Pulmonar, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Rio de Janeiro, RJ, Brasil.

Anais Da Academia Brasileira De Ciencias
|March 6, 2013
PubMed
Summary
This summary is machine-generated.

Nanoparticle formulations show promise for treating lung diseases by enabling targeted drug delivery. Further research is needed to bridge the gap between nanomedicine concepts and clinical application, addressing potential toxicity.

More Related Videos

Mechanical Dissociation of Tissues for Single Cell Analysis Using a Motorized Device
05:06

Mechanical Dissociation of Tissues for Single Cell Analysis Using a Motorized Device

Published on: November 10, 2023

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Related Experiment Videos

Last Updated: May 13, 2026

Intranasal Delivery of mRNA Polyplexes via Rayleigh Breakup Aerosols: An In Vitro Method for Nasal Deposition and Functional Testing
05:50

Intranasal Delivery of mRNA Polyplexes via Rayleigh Breakup Aerosols: An In Vitro Method for Nasal Deposition and Functional Testing

Published on: January 20, 2026

Mechanical Dissociation of Tissues for Single Cell Analysis Using a Motorized Device
05:06

Mechanical Dissociation of Tissues for Single Cell Analysis Using a Motorized Device

Published on: November 10, 2023

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Area of Science:

  • Nanotechnology
  • Materials Science
  • Pharmacotherapy

Background:

  • Nanotechnology involves manipulating matter at the nanometer scale (<100 nm) to create novel materials.
  • Nanoparticles exhibit size-dependent properties, enabling targeted drug delivery for improved pharmacotherapy.
  • This approach aims to minimize systemic side effects and toxicity in drug treatments.

Purpose of the Study:

  • To review published findings on nanoparticle formulations for lung diseases.
  • To summarize the potential benefits and challenges of nanotherapy in respiratory diseases.
  • To identify research gaps concerning nanomedicine's clinical translation and safety.

Main Methods:

  • Literature review of published experimental and clinical data.
  • Focus on nanoparticle formulations specifically for lung disease applications.
  • Analysis of data regarding therapeutic effects and systemic toxicity.

Main Results:

  • Nanoparticle-based therapies have demonstrated benefits in disease development and lung remodeling in respiratory diseases.
  • A significant gap exists between nanomedicine concepts and current clinical reality.
  • Further studies are essential to fully determine nanotherapy's potential and nanomaterial safety.

Conclusions:

  • Nanoparticle formulations offer potential advantages for treating lung diseases through targeted drug delivery.
  • Clinical translation of nanomedicine requires further investigation to overcome existing gaps.
  • Comprehensive studies on efficacy and systemic toxicity are crucial for the safe human application of nanomaterials.